BrainAurora Schedules 18 June 2026 Online AGM; Board Requests Fresh Share Issue and Buy-Back Mandates

Bulletin Express04-28

BrainAurora Medical Technology Limited will convene its 2026 annual general meeting online on 18 June 2026 at 10:00 a.m. (Hong Kong time).

Key agenda items 1. Financial statements: Shareholders will vote on the adoption of the audited consolidated results for the year ended 31 December 2025 together with the directors’ and auditor’s reports. 2. Board composition: Five directors are standing for re-election—non-executive directors Deng Feng, Yang Fan and Wang Jingbo, and independent non-executive directors Dr. Duan Tao and Tu Lei. 3. Directors’ remuneration: Authority to set directors’ fees will be delegated to the board if approved. 4. Auditor: Deloitte Touche Tohmatsu is nominated for re-appointment, with the board empowered to determine its remuneration. 5. Capital mandates: • General share-issuance mandate—up to 20% of the issued share capital (excluding treasury shares). • Share repurchase mandate—up to 10% of the issued share capital (excluding treasury shares). • Extension mandate—any shares repurchased under the 10% buy-back authority will be added to the 20% issuance limit.

Proxy and voting logistics • Deadline for lodging proxy forms: 10:00 a.m. on 16 June 2026 (48 hours before the meeting). • Each share carries one vote; shareholders may appoint a proxy who is not required to be a shareholder. • Joint holders will receive a single set of log-in credentials for online participation.

The meeting will be held entirely through the Vistra eVoting Portal, and attendance via the portal will supersede any previous proxy instructions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment